Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Jul 24;176:113888. doi: 10.1016/j.addr.2021.113888

Figure 10. Drug delivery systems used for treating liver fibrosis.

Figure 10.

Cell-specific receptors could be used for targeted delivery of nanomedicine for fibrosis/cirrhosis. (B) Ligand decoration on nanocarries facilitate receptor binding and uptake of compounds resulting in target cell-specific actions.